
Fit and healthy father-of-two left with 'locked-in syndrome' after suffering devastating health condition which is on the rise in under 50s
In April 2022, Gareth Bayley, from Bexley in South East London suffered from headaches for around a week, but shrugged them off as being caused by every day stress.
But, when the builder suddenly called his wife Karen to say he didn't feel well while at work, she knew something was wrong.
She rushed to his workplace where his colleagues told her he had collapsed and suffered a fit.
He was rushed to hospital where he continued to have seizures, but it wasn't until the next day that doctors realised he'd had a stroke.
Mr Bayley, who was only 38-years-old at the time, suffered a stroke in his brain stem, which meant it had life-altering consequences.
It led him to develop Locked-In Syndrome, a rare neurological condition that leaves a patient almost completely paralysed while remaining fully conscious.
Despite doctors telling the family the father would likely never move again, his wife says over three years later, he 'has defied every single expectation'.
While he cannot speak or move his limbs, he remains mentally alert—and has regained small but significant functions such as facial expressions.
He even communicates with his family through blinking, spelling out words one letter at a time.
Now, his wife and the kids are on a mission to raise £35,000 for life-changing equipment—that could help Gareth regain vital movement.
She said: 'Gareth is one in a million to me. He's very outgoing and the life and soul of the party. He was the first one there if anyone needed help.
'He is still him—he's fully there and remembers everything. It's just he can't speak or move.
'It's like he's trapped in his own body. Doctors told us he would likely never move again, apart from slight eye movements.
'But Gareth is a fighter. Over the past three years, he has regained some movement: he smiles, he laughs, and his expressions have returned in ways we were told might never happen.
'Every small step forward has given us hope that more recovery is possible.'
The family are even more hopeful as of late after hearing about a special piece of equipment called a Functional Electrical Stimulation Bike.
This is a rehabilitation device that uses electrical pulses to stimulate paralysed muscles and could enable Gareth's arms and legs to move together
However, it can only be sourced from the United States—and comes with a hefty price tag of £35,000.
She added: 'We did try to get it funded as he is in a care home, but because it was so expensive, the funding got refused as it wasn't deemed an 'essential piece of equipment'.
'But to us it is essential. If I can get him this bike it will be amazing.
'It would help increase his muscle strength, prevent pressure sores, improve the movement range with his arms and legs, help his joint mobility, and help his muscle spasms.
'It could give Gareth the best possible chance at further recovery, independence, and dignity.
Since his stroke, Gareth has been moved between hospitals, rehab centres, and care homes.
But his wife hopes he can live with her and the children again if they secure the bike.
She said: 'My husband has expressed that he wants to come home and be with me and the children again. But it's the case of getting the equipment.
'He has physio once a week in his care home and they've said if we can get the equipment, I can have training. The goal is then to have him back home again.'
His wife described the public's response to the father's story as overwhelmingly supportive.
The devoted wife said: 'It's been amazing. The response I've had from it has been fantastic.
'It's a little overwhelming—people who don't even know me or my husband have donated money and been so generous.
'It's been completely life-changing – he was 38 and I didn't associate a stroke with someone that age.
'But you don't know what can happen overnight, it's turned our world upside down.'
It comes amid a surge in stroke cases among young people, with those under 55 seeing cases soar by 67 per cent between 2002 and 2018.
Some experts believe may be due to younger people vaping, drinking alcohol and smoking weed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
35 minutes ago
- The Guardian
My friends had to subsidise the cost of running my vital oxygen therapy
I am dependent on long-term oxygen therapy after a double lung transplant. I'm entitled to reimbursement of the excess electricity used by the oxygen concentrator and have received quarterly payments of about £48 from Vivisol, which administers rebates on behalf of the NHS. However, I was forced to stay with friends and family for a year after my house was flooded, and I spent a further two months convalescing at my daughter's house after a heart operation. I received no rebates during that time, and Vivisol told me l would not be reimbursed while I was not living at home, which means my hosts had to subsidise my treatment. SS, East Sussex The rebate scheme is intended to protect eligible patients who rely on an oxygen concentrator from spiralling energy costs. I see that Vivisol's website states, in passing, that patients are eligible for the cost of using the machine at their main address. This strikes me as insufficiently clear, as well as potentially unfair. It's a no-brainer that those with such serious health issues might have to relocate, as you did, for convalescence, for respite care or building work. It seems unreasonable to me to expect friends and family to foot what can be a considerable bill for treatment and, since concentrators record electricity consumption on an integrated meter unconnected to the household meter, it is straightforward to be able to monitor the costs involved. I first approached NHS England to ask if this restriction was NHS policy and whether there were exemptions for cases such as yours. It referred me to the NHS Sussex Integrated Care Board, which explained that patients can nominate a temporary address as their main residence via their service provider in circumstances such as yours. In the meantime, Vivisol responded to my contact by agreeing to reinstate and backdate your rebates to cover the period while you were away. A spokesperson said: 'All communication does highlight that the eligibility only applies at the patient's main address. As a result of your email, we will review to identify if that can be made clearer.' We welcome letters but cannot answer individually. Email us at or write to Consumer Champions, Money, the Guardian, 90 York Way, London N1 9GU. Please include a daytime phone number. Submission and publication of all letters is subject to our terms and conditions.


Telegraph
35 minutes ago
- Telegraph
Free STI vaccines offered at health clinics
The Labour Government is calling on those who are sexually active and eligible to take up a free STI vaccine on the NHS. The world's first gonorrhoea vaccination programme is being rolled out by the NHS and local authorities and is now available at sexual health clinics in England for people at highest risk of infection. From Monday, clinics will be able to offer the free vaccine to those at highest risk of the sexually transmitted infection (STI), including gay and bisexual men who have a recent history of multiple sexual partners and a bacterial STI in the previous 12 months. Ashley Dalton, Minister for Public Health and Prevention, said: 'Rolling out this world-leading gonorrhoea vaccination programme in sexual health clinics in England represents a major breakthrough in preventing an infection that has reached record levels. 'This government's world-first vaccination programme will help turn the tide on infections, as well as tackling head-on the growing threat of antibiotic resistance. 'I strongly encourage anyone who is eligible to come forward for vaccination, to protect not only yourselves but also your sexual partners.' The vaccination programme comes at a critical time, with diagnoses of gonorrhoea reaching their highest levels since records began. In 2023, a record 85,000 cases of the disease were reported in England — three times higher than in 2012. The Government says this vaccine will protect thousands of people and save the NHS more than £7.9 million over the next decade. It will also help combat increasing levels of antibiotic-resistant strains of the disease. The vaccine that can now be offered to 'high-risk individuals' at local sexual health clinics is the existing vaccine for meningococcal disease (4CMenB) that also helps protect against gonorrhoea. Eligible patients attending clinics for the gonorrhoea vaccine will also be offered mpox, hepatitis A and B and human papillomavirus (HPV) vaccinations, which the Government says will provide comprehensive protection against an array of diseases. Dr Amanda Doyle, NHS national director for primary care and community services, said: 'The roll out of the NHS' world-first routine vaccination for gonorrhoea from this month is a real step-forward for sexual health and I know health service staff, alongside local authority colleagues, have been working hard to hit the ground running. 'This vaccine is already used to protect against Men B and is proven to be effective against gonorrhoea, preventing the spread of infection and reducing the rising rates of antibiotic-resistant strains. 'That is why it is so important that everyone eligible takes up the offer through sexual health services alongside existing jabs for mpox, Hep A & B, and HPV, helping ensure we keep each other safe.' Gonorrhoea is the second most common STI in the UK, and officials are becoming increasingly concerned that it could become 'untreatable' following a rise in an antibiotic-resistant strain from abroad. The programme will primarily target gay and bisexual men with a recent history of multiple sexual partners or a bacterial STI, who are at an increased risk of becoming infected. The UK Health Security Agency (UKHSA) data show there was a 9.4 per cent increase in gonorrhoea diagnoses among this group in 2023, with cases rising from 37,095 to 40,586. ENDS


The Independent
an hour ago
- The Independent
World-first vaccine rolled out across England amid record levels of infection
England has launched a world-first gonorrhoea vaccination programme, aimed at curbing soaring infection rates and tackling the growing threat of antibiotic-resistant strains. The initiative comes after cases of the sexually transmitted infection (STI) in England reached a record 85,000 in 2023, the highest since records began in 1918. Available free of charge from Monday at sexual health clinics, the jab is being offered to those at highest risk. This includes gay and bisexual men with a recent history of multiple sexual partners or a bacterial STI. The vaccine, an existing jab known as 4CMenB, is currently used to protect against meningococcal B disease, which can cause meningitis and sepsis. It is used in the routine childhood programme and given to babies at eight weeks, 16 weeks and one year. Officials anticipate the programme will save the NHS £7.9 million over the next decade. The programme could prevent up to 100,000 cases of gonorrhoea, according to doctors. The STI disproportionately impacts specific communities, such as those in deprived areas, people of black Caribbean ethnicity, and gay, bisexual and other men who have sex with men, according to the Joint Committee on Vaccination and Immunisation (JCVI). Patients getting the gonorrhoea vaccine will also be offered jabs for mpox, human papillomavirus (HPV), and hepatitis A and B at their appointment. 'Rolling out this world-leading gonorrhoea vaccination programme in sexual health clinics in England represents a major breakthrough in preventing an infection that has reached record levels,' Ashley Dalton, the minister for public health and prevention, said. 'This government's world-first vaccination programme will help turn the tide on infections, as well as tackling head-on the growing threat of antibiotic resistance. 'I strongly encourage anyone who is eligible to come forward for vaccination, to protect not only yourselves but also your sexual partners.'